MONSANTO POSITION 
 | 
INDIVIDUAL 
 | 
FEDERAL POSITION 
 | 
|---|---|---|
Senior Vice President for Clinical Affairs at G.D. Searle and Co. (merged with Monsanto) 
 | 
Michael A. Friedman 
 | 
Acting Commissioner of the FDA 
 | 
Consultant to Searle’s Public Relation Firm (merged with Monsanto) 
 | 
Arthur Hull Hayes 
 | 
Previously FDA Commissioner 
 | 
Top Monsanto Scientist, oversaw approval of rBGH 
 | 
Margaret Miller 
 | 
Appointed Deputy Director of FDA, 1991 
 | 
Worked on Monsanto-funded rBGH in connection with Cornell University 
 | 
Suzanne Sechen 
 | 
FDA Reviewer on Scientific Data 
 | 
Attorney for Monsanto for 7 years, previous Head of Monsanto Washington D.C. Office 
 | 
Michael Taylor 
 | 
Former FDA Deputy Commision for Policy. In 2010 appointed Senior Advisor to FDA Commissioner 
 | 
Former Monsanto Lawyer 
 | 
Clarence Thomas 
 | 
Appointed to U.S. Supreme Court in 1991 
 | 
Served on Board of Directors at Calgene, a Monsanto Biotech Subsidiary 
 | 
Anne Veneman 
 | 
Appointed head of USDA in 2001 
 | 
Retired Senior Vice President for Public Policy at Monsanto 
 | 
Dr. Virginia Weldon 
 | 
Previously, member of FDA’s Metabolism and Endocrine Advisory Committee 
 | 
Vice President, Public and Government Affairs 
 | 
Linda Fisher 
 | 
Deputy Administration EPA 
 | 
Manager, New Technologies 
 | 
Linda Watrud 
 | 
USDA, EPA 
 | 
Director, Monsanto Danforth Center 
 | 
Roger Beachy 
 | 
Director USDA, NIFA 
 | 
Fini
15 years ago




















No comments:
Post a Comment